Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Mayo Clinic Laboratories, |
RCV004792873 | SCV005410638 | uncertain significance | not provided | 2024-07-10 | criteria provided, single submitter | clinical testing | PM1_supporting |
| Ambry Genetics | RCV005353366 | SCV006024709 | uncertain significance | not specified | 2025-03-10 | criteria provided, single submitter | clinical testing | The c.517G>A (p.G173R) alteration is located in exon 6 (coding exon 5) of the KLKB1 gene. This alteration results from a G to A substitution at nucleotide position 517, causing the glycine (G) at amino acid position 173 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |